| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-12 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
7e-12 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-11 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-11 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
8e-11 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-09 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-08 |
| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
5e-08 |